Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit
Identifieur interne : 001425 ( Main/Corpus ); précédent : 001424; suivant : 001426Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit
Auteurs : Markus Nauck ; Winfried M Rz ; Heinrich WielandSource :
- Clinical Biochemistry [ 0009-9120 ] ; 2000.
Url:
DOI: 10.1016/S0009-9120(00)00056-4
Links to Exploration step
ISTEX:112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</title><author><name sortKey="Nauck, Markus" sort="Nauck, Markus" uniqKey="Nauck M" first="Markus" last="Nauck">Markus Nauck</name><affiliation><mods:affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence: Dr. Markus Nauck, Department of Medicine, Division of Clinical Chemistry, Hugstetter Strasse 55, 79106 Freiburg i. Br., Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: msnauck@med1.ukl.uni.freiburg.de</mods:affiliation></affiliation></author><author><name sortKey="M Rz, Winfried" sort="M Rz, Winfried" uniqKey="M Rz W" first="Winfried" last="M Rz">Winfried M Rz</name><affiliation><mods:affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</mods:affiliation></affiliation></author><author><name sortKey="Wieland, Heinrich" sort="Wieland, Heinrich" uniqKey="Wieland H" first="Heinrich" last="Wieland">Heinrich Wieland</name><affiliation><mods:affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0009-9120(00)00056-4</idno><idno type="url">https://api.istex.fr/document/112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001425</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</title><author><name sortKey="Nauck, Markus" sort="Nauck, Markus" uniqKey="Nauck M" first="Markus" last="Nauck">Markus Nauck</name><affiliation><mods:affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence: Dr. Markus Nauck, Department of Medicine, Division of Clinical Chemistry, Hugstetter Strasse 55, 79106 Freiburg i. Br., Germany</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: msnauck@med1.ukl.uni.freiburg.de</mods:affiliation></affiliation></author><author><name sortKey="M Rz, Winfried" sort="M Rz, Winfried" uniqKey="M Rz W" first="Winfried" last="M Rz">Winfried M Rz</name><affiliation><mods:affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</mods:affiliation></affiliation></author><author><name sortKey="Wieland, Heinrich" sort="Wieland, Heinrich" uniqKey="Wieland H" first="Heinrich" last="Wieland">Heinrich Wieland</name><affiliation><mods:affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Biochemistry</title><title level="j" type="abbrev">CLB</title><idno type="ISSN">0009-9120</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">33</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="213">213</biblScope><biblScope unit="page" to="216">216</biblScope></imprint><idno type="ISSN">0009-9120</idno></series><idno type="istex">112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91</idno><idno type="DOI">10.1016/S0009-9120(00)00056-4</idno><idno type="PII">S0009-9120(00)00056-4</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0009-9120</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Markus Nauck</name><affiliations><json:string>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</json:string><json:string>Correspondence: Dr. Markus Nauck, Department of Medicine, Division of Clinical Chemistry, Hugstetter Strasse 55, 79106 Freiburg i. Br., Germany</json:string><json:string>E-mail: msnauck@med1.ukl.uni.freiburg.de</json:string></affiliations></json:item><json:item><name>Winfried März</name><affiliations><json:string>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</json:string></affiliations></json:item><json:item><name>Heinrich Wieland</name><affiliations><json:string>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Capsule</value></json:item></subject><language><json:string>eng</json:string></language><qualityIndicators><score>1.966</score><pdfVersion>1.2</pdfVersion><pdfPageSize>596 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>1</keywordCount><abstractCharCount>0</abstractCharCount><pdfWordCount>1954</pdfWordCount><pdfCharCount>12510</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>1</abstractWordCount></qualityIndicators><title>Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</title><pii><json:string>S0009-9120(00)00056-4</json:string></pii><genre><json:string>brief communication</json:string></genre><host><volume>33</volume><pii><json:string>S0009-9120(00)X0039-2</json:string></pii><pages><last>216</last><first>213</first></pages><issn><json:string>0009-9120</json:string></issn><issue>3</issue><genre></genre><language><json:string>unknown</json:string></language><title>Clinical Biochemistry</title><publicationDate>2000</publicationDate></host><categories><wos><json:string>MEDICINE, GENERAL & INTERNAL</json:string><json:string>BIOCHEMISTRY & MOLECULAR BIOLOGY</json:string><json:string>MEDICAL LABORATORY TECHNOLOGY</json:string></wos></categories><publicationDate>2000</publicationDate><copyrightDate>2000</copyrightDate><doi><json:string>10.1016/S0009-9120(00)00056-4</json:string></doi><id>112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>2000</date></publicationStmt><notesStmt><note type="content">Section title: Capsule</note><note type="content">Figure 1: Detection of the factor V Leiden (a) and the prothrombin mutation (b) with allele-specific fluorescent probes by derivative melting curve plots. Data of the fluorescence signal (F) were obtained during the melting transition of the fluorescein-labeled detection probe from the amplified fragment. Fluorescence data were converted to derivative melting curves by plotting the negative derivative of the fluorescence with respect to temperature against temperature (−(dF/dT) vs. T). The derivative melting curve is plotted for a sample homozygous for wild-type allele (A), a heterozygous sample (B), and a sample homozygous for the mutant allele (C). Melting analysis of a no template control (D) was also performed.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</title><author><persName><forename type="first">Markus</forename><surname>Nauck</surname></persName><email>msnauck@med1.ukl.uni.freiburg.de</email><affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</affiliation><affiliation>Correspondence: Dr. Markus Nauck, Department of Medicine, Division of Clinical Chemistry, Hugstetter Strasse 55, 79106 Freiburg i. Br., Germany</affiliation></author><author><persName><forename type="first">Winfried</forename><surname>März</surname></persName><affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</affiliation></author><author><persName><forename type="first">Heinrich</forename><surname>Wieland</surname></persName><affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</affiliation></author></analytic><monogr><title level="j">Clinical Biochemistry</title><title level="j" type="abbrev">CLB</title><idno type="pISSN">0009-9120</idno><idno type="PII">S0009-9120(00)X0039-2</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000"></date><biblScope unit="volume">33</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="213">213</biblScope><biblScope unit="page" to="216">216</biblScope></imprint></monogr><idno type="istex">112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91</idno><idno type="DOI">10.1016/S0009-9120(00)00056-4</idno><idno type="PII">S0009-9120(00)00056-4</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2000</date></creation><langUsage><language ident="en">en</language></langUsage><textClass><keywords scheme="keyword"><list><head>Article category</head><item><term>Capsule</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2000-01-07">Registration</change><change when="2000-01-04">Modified</change><change when="2000">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: ce:floats; body; tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"><istex:entity SYSTEM="gr1" NDATA="IMAGE" name="GR1"></istex:entity></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="sco" xml:lang="en"><item-info><jid>CLB</jid><aid>5358</aid><ce:pii>S0009-9120(00)00056-4</ce:pii><ce:doi>10.1016/S0009-9120(00)00056-4</ce:doi><ce:copyright type="society" year="2000">The Canadian Society of Clinical Chemists</ce:copyright><ce:doctopics><ce:doctopic><ce:text>Capsule</ce:text></ce:doctopic></ce:doctopics></item-info><head><ce:dochead><ce:textfn>Capsule</ce:textfn></ce:dochead><ce:title>Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</ce:title><ce:author-group><ce:author><ce:given-name>Markus</ce:given-name><ce:surname>Nauck</ce:surname><ce:cross-ref refid="AFF1"><ce:sup>a</ce:sup></ce:cross-ref><ce:cross-ref refid="CORR1">*</ce:cross-ref><ce:e-address>msnauck@med1.ukl.uni.freiburg.de</ce:e-address></ce:author><ce:author><ce:indexed-name>Marz</ce:indexed-name><ce:given-name>Winfried</ce:given-name><ce:surname>März</ce:surname><ce:cross-ref refid="AFF1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Heinrich</ce:given-name><ce:surname>Wieland</ce:surname><ce:cross-ref refid="AFF1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="AFF1"><ce:label>a</ce:label><ce:textfn>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</ce:textfn></ce:affiliation><ce:correspondence id="CORR1"><ce:label>*</ce:label><ce:text>Correspondence: Dr. Markus Nauck, Department of Medicine, Division of Clinical Chemistry, Hugstetter Strasse 55, 79106 Freiburg i. Br., Germany</ce:text></ce:correspondence></ce:author-group><ce:date-received day="23" month="11" year="1999"></ce:date-received><ce:date-revised day="4" month="1" year="2000"></ce:date-revised><ce:date-accepted day="7" month="1" year="2000"></ce:date-accepted></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit</title></titleInfo><name type="personal"><namePart type="given">Markus</namePart><namePart type="family">Nauck</namePart><affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</affiliation><affiliation>Correspondence: Dr. Markus Nauck, Department of Medicine, Division of Clinical Chemistry, Hugstetter Strasse 55, 79106 Freiburg i. Br., Germany</affiliation><affiliation>E-mail: msnauck@med1.ukl.uni.freiburg.de</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Winfried</namePart><namePart type="family">März</namePart><affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Heinrich</namePart><namePart type="family">Wieland</namePart><affiliation>Department of Clinical Chemistry, University Hospital, Freiburg, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief communication" displayLabel="Short communication"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">2000</dateIssued><dateValid encoding="w3cdtf">2000-01-07</dateValid><dateModified encoding="w3cdtf">2000-01-04</dateModified><copyrightDate encoding="w3cdtf">2000</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><note type="content">Section title: Capsule</note><note type="content">Figure 1: Detection of the factor V Leiden (a) and the prothrombin mutation (b) with allele-specific fluorescent probes by derivative melting curve plots. Data of the fluorescence signal (F) were obtained during the melting transition of the fluorescein-labeled detection probe from the amplified fragment. Fluorescence data were converted to derivative melting curves by plotting the negative derivative of the fluorescence with respect to temperature against temperature (−(dF/dT) vs. T). The derivative melting curve is plotted for a sample homozygous for wild-type allele (A), a heterozygous sample (B), and a sample homozygous for the mutant allele (C). Melting analysis of a no template control (D) was also performed.</note><subject><genre>Article category</genre><topic>Capsule</topic></subject><relatedItem type="host"><titleInfo><title>Clinical Biochemistry</title></titleInfo><titleInfo type="abbreviated"><title>CLB</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">200004</dateIssued></originInfo><identifier type="ISSN">0009-9120</identifier><identifier type="PII">S0009-9120(00)X0039-2</identifier><part><date>200004</date><detail type="volume"><number>33</number><caption>vol.</caption></detail><detail type="issue"><number>3</number><caption>no.</caption></detail><extent unit="issue pages"><start>161</start><end>242</end></extent><extent unit="pages"><start>213</start><end>216</end></extent></part></relatedItem><identifier type="istex">112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91</identifier><identifier type="DOI">10.1016/S0009-9120(00)00056-4</identifier><identifier type="PII">S0009-9120(00)00056-4</identifier><accessCondition type="use and reproduction" contentType="">© 2000The Canadian Society of Clinical Chemists</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>The Canadian Society of Clinical Chemists, ©2000</recordOrigin></recordInfo></mods></metadata><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">MEDICINE, GENERAL & INTERNAL</classCode><classCode scheme="WOS">BIOCHEMISTRY & MOLECULAR BIOLOGY</classCode><classCode scheme="WOS">MEDICAL LABORATORY TECHNOLOGY</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/SchutzV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001425 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001425 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= SchutzV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:112F2DAAB27F9FAE641C2833DBF8EEDEC492EE91
|texte= Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit
}}
| This area was generated with Dilib version V0.6.38. |  |